Cargando…

Who should be prioritized for COVID-19 vaccination in China? A descriptive study

BACKGROUND: All countries are facing decisions about which population groups to prioritize for access to COVID-19 vaccination after the first vaccine products have been licensed, at which time supply shortages are inevitable. Our objective is to define the key target populations, their size, and pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Juan, Zheng, Wen, Shi, Huilin, Yan, Xuemei, Dong, Kaige, You, Qian, Zhong, Guangjie, Gong, Hui, Chen, Zhiyuan, Jit, Mark, Viboud, Cecile, Ajelli, Marco, Yu, Hongjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872877/
https://www.ncbi.nlm.nih.gov/pubmed/33563270
http://dx.doi.org/10.1186/s12916-021-01923-8
_version_ 1783649274625523712
author Yang, Juan
Zheng, Wen
Shi, Huilin
Yan, Xuemei
Dong, Kaige
You, Qian
Zhong, Guangjie
Gong, Hui
Chen, Zhiyuan
Jit, Mark
Viboud, Cecile
Ajelli, Marco
Yu, Hongjie
author_facet Yang, Juan
Zheng, Wen
Shi, Huilin
Yan, Xuemei
Dong, Kaige
You, Qian
Zhong, Guangjie
Gong, Hui
Chen, Zhiyuan
Jit, Mark
Viboud, Cecile
Ajelli, Marco
Yu, Hongjie
author_sort Yang, Juan
collection PubMed
description BACKGROUND: All countries are facing decisions about which population groups to prioritize for access to COVID-19 vaccination after the first vaccine products have been licensed, at which time supply shortages are inevitable. Our objective is to define the key target populations, their size, and priority for a COVID-19 vaccination program in the context of China. METHODS: On the basis of utilitarian and egalitarian principles, we define and estimate the size of tiered target population groups for a phased introduction of COVID-19 vaccination, considering evolving goals as vaccine supplies increase, detailed information on the risk of illness and transmission, and past experience with vaccination during the 2009 influenza pandemic. Using publicly available data, we estimated the size of target population groups, and the number of days needed to vaccinate 70% of the target population. Sensitivity analyses considered higher vaccine coverages and scaled up vaccine delivery relative to the 2009 pandemic. RESULTS: Essential workers, including staff in the healthcare, law enforcement, security, nursing homes, social welfare institutes, community services, energy, food and transportation sectors, and overseas workers/students (49.7 million) could be prioritized for vaccination to maintain essential services in the early phase of a vaccination program. Subsequently, older adults, individuals with underlying health conditions and pregnant women (563.6 million) could be targeted for vaccination to reduce the number of individuals with severe COVID-19 outcomes, including hospitalizations, critical care admissions, and deaths. In later stages, the vaccination program could be further extended to target adults without underlying health conditions and children (784.8 million), in order to reduce symptomatic infections and/or to stop virus transmission. Given 10 million doses administered per day, and a two-dose vaccination schedule, it would take 1 week to vaccinate essential workers but likely up to 7 months to vaccinate 70% of the overall population. CONCLUSIONS: The proposed framework is general but could assist Chinese policy-makers in the design of a vaccination program. Additionally, this exercise could be generalized to inform other national and regional strategies for use of COVID-19 vaccines, especially in low- and middle-income countries. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-01923-8.
format Online
Article
Text
id pubmed-7872877
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78728772021-02-10 Who should be prioritized for COVID-19 vaccination in China? A descriptive study Yang, Juan Zheng, Wen Shi, Huilin Yan, Xuemei Dong, Kaige You, Qian Zhong, Guangjie Gong, Hui Chen, Zhiyuan Jit, Mark Viboud, Cecile Ajelli, Marco Yu, Hongjie BMC Med Research Article BACKGROUND: All countries are facing decisions about which population groups to prioritize for access to COVID-19 vaccination after the first vaccine products have been licensed, at which time supply shortages are inevitable. Our objective is to define the key target populations, their size, and priority for a COVID-19 vaccination program in the context of China. METHODS: On the basis of utilitarian and egalitarian principles, we define and estimate the size of tiered target population groups for a phased introduction of COVID-19 vaccination, considering evolving goals as vaccine supplies increase, detailed information on the risk of illness and transmission, and past experience with vaccination during the 2009 influenza pandemic. Using publicly available data, we estimated the size of target population groups, and the number of days needed to vaccinate 70% of the target population. Sensitivity analyses considered higher vaccine coverages and scaled up vaccine delivery relative to the 2009 pandemic. RESULTS: Essential workers, including staff in the healthcare, law enforcement, security, nursing homes, social welfare institutes, community services, energy, food and transportation sectors, and overseas workers/students (49.7 million) could be prioritized for vaccination to maintain essential services in the early phase of a vaccination program. Subsequently, older adults, individuals with underlying health conditions and pregnant women (563.6 million) could be targeted for vaccination to reduce the number of individuals with severe COVID-19 outcomes, including hospitalizations, critical care admissions, and deaths. In later stages, the vaccination program could be further extended to target adults without underlying health conditions and children (784.8 million), in order to reduce symptomatic infections and/or to stop virus transmission. Given 10 million doses administered per day, and a two-dose vaccination schedule, it would take 1 week to vaccinate essential workers but likely up to 7 months to vaccinate 70% of the overall population. CONCLUSIONS: The proposed framework is general but could assist Chinese policy-makers in the design of a vaccination program. Additionally, this exercise could be generalized to inform other national and regional strategies for use of COVID-19 vaccines, especially in low- and middle-income countries. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-01923-8. BioMed Central 2021-02-10 /pmc/articles/PMC7872877/ /pubmed/33563270 http://dx.doi.org/10.1186/s12916-021-01923-8 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Yang, Juan
Zheng, Wen
Shi, Huilin
Yan, Xuemei
Dong, Kaige
You, Qian
Zhong, Guangjie
Gong, Hui
Chen, Zhiyuan
Jit, Mark
Viboud, Cecile
Ajelli, Marco
Yu, Hongjie
Who should be prioritized for COVID-19 vaccination in China? A descriptive study
title Who should be prioritized for COVID-19 vaccination in China? A descriptive study
title_full Who should be prioritized for COVID-19 vaccination in China? A descriptive study
title_fullStr Who should be prioritized for COVID-19 vaccination in China? A descriptive study
title_full_unstemmed Who should be prioritized for COVID-19 vaccination in China? A descriptive study
title_short Who should be prioritized for COVID-19 vaccination in China? A descriptive study
title_sort who should be prioritized for covid-19 vaccination in china? a descriptive study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872877/
https://www.ncbi.nlm.nih.gov/pubmed/33563270
http://dx.doi.org/10.1186/s12916-021-01923-8
work_keys_str_mv AT yangjuan whoshouldbeprioritizedforcovid19vaccinationinchinaadescriptivestudy
AT zhengwen whoshouldbeprioritizedforcovid19vaccinationinchinaadescriptivestudy
AT shihuilin whoshouldbeprioritizedforcovid19vaccinationinchinaadescriptivestudy
AT yanxuemei whoshouldbeprioritizedforcovid19vaccinationinchinaadescriptivestudy
AT dongkaige whoshouldbeprioritizedforcovid19vaccinationinchinaadescriptivestudy
AT youqian whoshouldbeprioritizedforcovid19vaccinationinchinaadescriptivestudy
AT zhongguangjie whoshouldbeprioritizedforcovid19vaccinationinchinaadescriptivestudy
AT gonghui whoshouldbeprioritizedforcovid19vaccinationinchinaadescriptivestudy
AT chenzhiyuan whoshouldbeprioritizedforcovid19vaccinationinchinaadescriptivestudy
AT jitmark whoshouldbeprioritizedforcovid19vaccinationinchinaadescriptivestudy
AT viboudcecile whoshouldbeprioritizedforcovid19vaccinationinchinaadescriptivestudy
AT ajellimarco whoshouldbeprioritizedforcovid19vaccinationinchinaadescriptivestudy
AT yuhongjie whoshouldbeprioritizedforcovid19vaccinationinchinaadescriptivestudy